EMEA-002685-PIP02-19-M01
Key facts
| Invented name |
Vumerity
|
| Active substance |
Diroximel fumarate (BIIB098)
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0413/2022
|
| PIP number |
EMEA-002685-PIP02-19-M01
|
| Pharmaceutical form(s) |
Gastro-resistant capsule, hard
|
| Condition(s) / indication(s) |
Treatment of multiple sclerosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Biogen Netherlands B.V.
E-mail: pip.enquiries@biogen.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|